Lind Global Fund II LP 13D and 13G filings for ASLAN Pharmaceuticals Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:15 pm Sale |
2024-09-30 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Lind Global Fund II LP | 0 0.000% |
-156,250 (Position Closed) |
Filing |
| 2024-03-19 4:30 pm Purchase |
2024-03-14 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Lind Global Fund II LP | 156,250 5.700% |
156,250 (New Position) |
Filing |